Chemo-Free Regimen Boosts OS in Mesothelioma Big advantage for nivolumab-ipilimumab in nonepithelioid tumors drives advantage over chemo Aug 09, 2020
Another ALK Drug Tops Crizotinib in First-Line NSCLC Ensartinib doubled PFS over older standard, with improved CNS activity Aug 08, 2020
COVID-19 More Deadly Than Cancer Itself? Highlights from the AACR conference on COVID-19 and cancer Jul 24, 2020
The Serious Conversation: Delivering Bad News by Telemedicine As office visits move online, clinicians discuss breaking life-changing diagnoses virtually Jul 13, 2020
Cancer Immunotherapy Tied to Severe COVID-19 Outcomes Nearly threefold increased risk of hospitalization, severe respiratory illness Jun 25, 2020
Paradigm Shift Coming for Early NSCLC? Postoperative osimertinib doubles DFS in patients with stages Ib-IIIa EGFR+ lung cancer May 28, 2020
End of Life and COVID-19; DCIS Doubles Cancer Risk; Training for 'Bad News' News, features, and commentary about cancer-related issues May 28, 2020
6-Week Keytruda Safe, Effective in Melanoma Schedule gets FDA approval for all adult indications Apr 30, 2020
COVID-19 Mortality Spikes in Patients With Lung, Blood Cancers Those with metastatic disease also at special risk for poor outcomes Apr 28, 2020
How Prevalent Is Checkpoint Inhibitor Thyroid Dysfunction, Really? Real-world data offer word of caution for oncologists Apr 01, 2020
DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
No DNA Damage Seen With Single Low-Dose CT Scan Some reassurance for annual lung cancer screening safety Mar 10, 2020
PD-1 vs PD-L1 Inhibitors: Do Outcomes Differ? Meta-analysis suggests they aren't equivalent Dec 27, 2019
Pembrolizumab Shows Survival Benefit in KRAS-Mutant NSCLC Improved OS, PFS, and response rates compared to chemo in first-line Dec 16, 2019
AHA Dedicates $20 Million to Youth Vaping Research Association and partners aim to "hold e-cigarette companies publicly accountable for their lies" Nov 16, 2019
Rheumatoid Arthritis Is No Bar to Cancer Immunotherapy Small study finds flares common with checkpoint inhibitors, but few patients stopped treatment because of them Nov 13, 2019
Notable OS Gains with Dual Immunotherapy in Advanced NSCLC Secondary analysis of CheckMate 227 brings more good news for nivolumab-ipilimumab combo Sep 28, 2019
BCG Vax: A Shot Against Lung Cancer in Native Populations? 60-year follow-up data from a vaccine trial found surprising results Sep 25, 2019
Post-Immunotherapy SBRT Boosts Outcomes in Advanced NSCLC Increased systemic response rate, disease control rate, and PFS in phase II trial Sep 17, 2019
Anti-PD-1/L1 for NSCLC Sparks Talk of the 'C' Word Unprecedented survival at 3 and 5 years, but investigators reluctant to say "cure" Sep 10, 2019
'Dirtier' Drugs Step Aside in RET-Positive NSCLC Over two-thirds of patients respond to selective RET inhibitor Sep 09, 2019
TMB in Lung Cancer: 'Not Ready for Prime Time' No association between tumor mutational burden and outcomes in three trials Sep 09, 2019
Small Cancer Risk With Lung Micronodules Supports classifying small nodules as negative scan result Jul 10, 2019
More Clarity to Steroids' Effect on Anti-PD-1 Therapy Adverse effects driven by palliative indications associated with poor prognosis Jun 27, 2019
Rheumatologist's Primer on Checkpoint Inhibitors Specialist reviews the landscape of cancer drugs' autoimmune side effects Apr 09, 2019
Durable Responses With Keytruda in Later-Line SCLC Plus umbralisib in marginal zone lymphoma and a next-generation TRK-targeted agent Apr 04, 2019
MET Inhibitor Rescues Some Targeted Tx Failures in NSCLC Savolitinib promising in patients with MET-based resistance to EGFR inhibition Apr 01, 2019 video
CAR T-Cell Therapy Active in Solid Tumors Preliminary data on safety, efficacy in mesothelioma, sarcomas Mar 31, 2019 video
Aggressive Tx in Oligometastatic NSCLC Tied to Improved OS Histology, intrathoracic disease burden, and bone metastases may predict outcomes Mar 12, 2019
Liquid Biopsy Matches Tissue for NSCLC Guidance Increased mutation detection rate, faster turnaround time Feb 27, 2019
Rapid Heart Rate Tied to Higher Mortality in Cancer Patients Unexplained tachycardia linked with threefold increase in risk of death Jan 28, 2019
Cancer Treatment and Arthritis: A Growing Complaint Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
Increased Risk of Chemo-Associated AML for Nearly All Solid Cancers Extended beyond 5 years for most types with greater risk seen in young patients Dec 20, 2018
Immunotherapy Combo Flops in Metastatic NSCLC Durvalumab plus tremelimumab failed to improve survival versus chemotherapy Dec 13, 2018
Highlights from Molecular Targets Symposiuim Breast cancer gene expression, activity in GI, lung, and limited-mutation tumors Nov 16, 2018
Group of Blood Pressure Drugs Linked to Lung Cancer 14% higher likelihood in users of ACE inhibitors; causal relationship unproven Oct 25, 2018
